• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Botox

AbbVie booth at AACR 2026
Marketing

AbbVie’s Skyrizi leading drug in pharma’s ad spending league

AbbVie retook the top spot from rival J&J and its immunology drug Tremfya in July’s top TV drug ad spending rankings.
Ben Adams Aug 7, 2026 9:45am
migraine headache

Ipsen’s Botox rival Dysport posts dual ph. 3 wins in migraine

Jul 9, 2026 10:36am
two red lights

AbbVie, Grace Therapeutics receive manufacturing-related CRLs

Apr 24, 2026 11:37am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

AbbVie sues HHS, CMS over Botox's inclusion in IRA price talks

Feb 12, 2026 1:45am
Free preventive services under the ACA are being challenged

AbbVie awarded $56M in Botox patent infringement case

Jul 22, 2025 11:22am
A chessboard with blocks that read MA

Revance is being bought up by Crown Laboratories for $924M

Aug 12, 2024 2:45pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings